Comprehensive genetic sequencing continues to gain rapid ground as a diagnostic testing strategy. Diagnostic success rates have led to recommendations for WGS as a first-tier diagnostic test, increased coverage by third-party payors, and decreased time to diagnosis. This white paper provides an overview of the current state of WGS testing, supporting clinical data, and clinical applications.